FDA’s Advisory Committee seconds Actavis’s (ACT) Antibiotic for FDA Approval

December 7, 2014 9:30 AM

3 0

FDA’s Anti-Infective Drugs Advisory Committee has recommended Actavis’s experimental drug ceftazidime-avibactam to treat patients suffering from complicated intra-abdominal infections cIAI and complicated urinary tract infections cUTI.

Since the drug is being produced in joint venture-ship with AstraZeneca plc, therefore an agreement has been made so that Actavis owns the rights for the drug in North America, whereas in other countries, the rights are held by AstraZeneca.

Read more

To category page